 | • レポートコード：GIR201107462 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、処方用関節炎薬の世界市場を調査対象にし、処方用関節炎薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（経口、局所）、用途別分析（病院薬局、オンライン薬局、小売薬局）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Abbott、Horizon Pharma、Amgen、Regeneron、Boehringer Ingelheim、Pfizer、Novartis ・メーカー別販売量、売上、市場シェア ・処方用関節炎薬の地域別市場分析 ・処方用関節炎薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・処方用関節炎薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・処方用関節炎薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・処方用関節炎薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・処方用関節炎薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・処方用関節炎薬の種類別市場規模2015-2020：経口、局所 ・処方用関節炎薬の用途別市場規模2015-2020：病院薬局、オンライン薬局、小売薬局 ・処方用関節炎薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Prescription Arthritis Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Prescription Arthritis Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Prescription Arthritis Medications market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Prescription Arthritis Medications market has been segmented into
Oral
Topical
By Application, Prescription Arthritis Medications has been segmented into:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prescription Arthritis Medications market presented in the report. This section sheds light on the sales growth of different regional and country-level Prescription Arthritis Medications markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prescription Arthritis Medications market.
The report offers in-depth assessment of the growth and other aspects of the Prescription Arthritis Medications market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Prescription Arthritis Medications Market Share Analysis
Prescription Arthritis Medications competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prescription Arthritis Medications sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prescription Arthritis Medications sales, revenue and market share for each player covered in this report.
The major players covered in Prescription Arthritis Medications are:
Abbott
Horizon Pharma
Amgen
Regeneron
Boehringer Ingelheim
Pfizer
Novartis
Among other players domestic and global, Prescription Arthritis Medications market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prescription Arthritis Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prescription Arthritis Medications, with price, sales, revenue and global market share of Prescription Arthritis Medications in 2018 and 2019.
Chapter 3, the Prescription Arthritis Medications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prescription Arthritis Medications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Prescription Arthritis Medications market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Prescription Arthritis Medications sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Prescription Arthritis Medications Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prescription Arthritis Medications Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Topical
1.3 Market Analysis by Application
1.3.1 Overview: Global Prescription Arthritis Medications Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Overview of Global Prescription Arthritis Medications Market
1.4.1 Global Prescription Arthritis Medications Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Horizon Pharma
2.2.1 Horizon Pharma Details
2.2.2 Horizon Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Horizon Pharma SWOT Analysis
2.2.4 Horizon Pharma Product and Services
2.2.5 Horizon Pharma Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen SWOT Analysis
2.3.4 Amgen Product and Services
2.3.5 Amgen Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Regeneron
2.4.1 Regeneron Details
2.4.2 Regeneron Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Regeneron SWOT Analysis
2.4.4 Regeneron Product and Services
2.4.5 Regeneron Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Boehringer Ingelheim SWOT Analysis
2.5.4 Boehringer Ingelheim Product and Services
2.5.5 Boehringer Ingelheim Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis SWOT Analysis
2.7.4 Novartis Product and Services
2.7.5 Novartis Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Prescription Arthritis Medications Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Prescription Arthritis Medications Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Prescription Arthritis Medications Manufacturer Market Share in 2019
3.3.2 Top 6 Prescription Arthritis Medications Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Prescription Arthritis Medications Sales, Revenue and Market Share by Regions
4.1.1 Global Prescription Arthritis Medications Sales and Market Share by Regions (2015-2020)
4.1.2 Global Prescription Arthritis Medications Revenue and Market Share by Regions (2015-2020)
4.2 North America Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
4.3 Europe Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
4.5 South America Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Prescription Arthritis Medications Sales, Revenue and Market Share by Country
5.1.1 North America Prescription Arthritis Medications Sales and Market Share by Country (2015-2020)
5.1.2 North America Prescription Arthritis Medications Revenue and Market Share by Country (2015-2020)
5.2 United States Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
5.3 Canada Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
5.4 Mexico Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Prescription Arthritis Medications Sales, Revenue and Market Share by Country
6.1.1 Europe Prescription Arthritis Medications Sales and Market Share by Country (2015-2020)
6.1.2 Europe Prescription Arthritis Medications Revenue and Market Share by Country (2015-2020)
6.2 Germany Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
6.3 UK Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
6.4 France Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
6.5 Russia Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
6.6 Italy Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Prescription Arthritis Medications Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Prescription Arthritis Medications Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Prescription Arthritis Medications Revenue and Market Share by Regions (2015-2020)
7.2 China Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
7.3 Japan Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
7.4 Korea Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
7.5 India Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
7.7 Australia Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Prescription Arthritis Medications Sales, Revenue and Market Share by Country
8.1.1 South America Prescription Arthritis Medications Sales and Market Share by Country (2015-2020)
8.1.2 South America Prescription Arthritis Medications Revenue and Market Share by Country (2015-2020)
8.2 Brazil Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
8.3 Argentina Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Prescription Arthritis Medications Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Prescription Arthritis Medications Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Prescription Arthritis Medications Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
9.3 Turkey Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
9.4 Egypt Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
9.5 South Africa Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Prescription Arthritis Medications Sales and Market Share by Type (2015-2020)
10.2 Global Prescription Arthritis Medications Revenue and Market Share by Type (2015-2020)
10.3 Global Prescription Arthritis Medications Price by Type (2015-2020)
11 Global Prescription Arthritis Medications Market Segment by Application
11.1 Global Prescription Arthritis Medications Sales Market Share by Application (2015-2020)
11.2 Global Prescription Arthritis Medications Revenue Market Share by Application (2015-2020)
11.3 Global Prescription Arthritis Medications Price by Application (2015-2020)
12 Market Forecast
12.1 Global Prescription Arthritis Medications Sales, Revenue and Growth Rate (2021-2025)
12.2 Prescription Arthritis Medications Market Forecast by Regions (2021-2025)
12.2.1 North America Prescription Arthritis Medications Market Forecast (2021-2025)
12.2.2 Europe Prescription Arthritis Medications Market Forecast (2021-2025)
12.2.3 Asia-Pacific Prescription Arthritis Medications Market Forecast (2021-2025)
12.2.4 South America Prescription Arthritis Medications Market Forecast (2021-2025)
12.2.5 Middle East & Africa Prescription Arthritis Medications Market Forecast (2021-2025)
12.3 Prescription Arthritis Medications Market Forecast by Type (2021-2025)
12.3.1 Global Prescription Arthritis Medications Sales Forecast by Type (2021-2025)
12.3.2 Global Prescription Arthritis Medications Market Share Forecast by Type (2021-2025)
12.4 Prescription Arthritis Medications Market Forecast by Application (2021-2025)
12.4.1 Global Prescription Arthritis Medications Sales Forecast by Application (2021-2025)
12.4.2 Global Prescription Arthritis Medications Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Prescription Arthritis Medications Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prescription Arthritis Medications by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prescription Arthritis Medications Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abbott Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Prescription Arthritis Medications Major Business
Table 9. Abbott Prescription Arthritis Medications Total Revenue (USD Million) (2018-2019)
Table 10. Abbott SWOT Analysis
Table 11. Abbott Prescription Arthritis Medications Product and Services
Table 12. Abbott Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Horizon Pharma Prescription Arthritis Medications Major Business
Table 15. Horizon Pharma Prescription Arthritis Medications Total Revenue (USD Million) (2018-2019)
Table 16. Horizon Pharma SWOT Analysis
Table 17. Horizon Pharma Prescription Arthritis Medications Product and Services
Table 18. Horizon Pharma Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Amgen Basic Information, Manufacturing Base and Competitors
Table 20. Amgen Prescription Arthritis Medications Major Business
Table 21. Amgen Prescription Arthritis Medications Total Revenue (USD Million) (2018-2019)
Table 22. Amgen SWOT Analysis
Table 23. Amgen Prescription Arthritis Medications Product and Services
Table 24. Amgen Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Regeneron Basic Information, Manufacturing Base and Competitors
Table 26. Regeneron Prescription Arthritis Medications Major Business
Table 27. Regeneron Prescription Arthritis Medications Total Revenue (USD Million) (2018-2019)
Table 28. Regeneron SWOT Analysis
Table 29. Regeneron Prescription Arthritis Medications Product and Services
Table 30. Regeneron Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 32. Boehringer Ingelheim Prescription Arthritis Medications Major Business
Table 33. Boehringer Ingelheim Prescription Arthritis Medications Total Revenue (USD Million) (2018-2019)
Table 34. Boehringer Ingelheim SWOT Analysis
Table 35. Boehringer Ingelheim Prescription Arthritis Medications Product and Services
Table 36. Boehringer Ingelheim Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Prescription Arthritis Medications Major Business
Table 39. Pfizer Prescription Arthritis Medications Total Revenue (USD Million) (2018-2019)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer Prescription Arthritis Medications Product and Services
Table 42. Pfizer Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Prescription Arthritis Medications Major Business
Table 45. Novartis Prescription Arthritis Medications Total Revenue (USD Million) (2018-2019)
Table 46. Novartis SWOT Analysis
Table 47. Novartis Prescription Arthritis Medications Product and Services
Table 48. Novartis Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Prescription Arthritis Medications Sales by Manufacturer (2018-2019) (K Units)
Table 50. Global Prescription Arthritis Medications Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Prescription Arthritis Medications Sales by Regions (2015-2020) (K Units)
Table 52. Global Prescription Arthritis Medications Sales Market Share by Regions (2015-2020)
Table 53. Global Prescription Arthritis Medications Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Prescription Arthritis Medications Sales by Countries (2015-2020) (K Units)
Table 55. North America Prescription Arthritis Medications Sales Market Share by Countries (2015-2020)
Table 56. North America Prescription Arthritis Medications Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Prescription Arthritis Medications Revenue Market Share by Countries (2015-2020)
Table 58. Europe Prescription Arthritis Medications Sales by Countries (2015-2020) (K Units)
Table 59. Europe Prescription Arthritis Medications Sales Market Share by Countries (2015-2020)
Table 60. Europe Prescription Arthritis Medications Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Prescription Arthritis Medications Sales by Regions (2015-2020) (K Units)
Table 62. Asia-Pacific Prescription Arthritis Medications Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Prescription Arthritis Medications Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Prescription Arthritis Medications Sales by Countries (2015-2020) (K Units)
Table 65. South America Prescription Arthritis Medications Sales Market Share by Countries (2015-2020)
Table 66. South America Prescription Arthritis Medications Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Prescription Arthritis Medications Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Prescription Arthritis Medications Sales by Countries (2015-2020) (K Units)
Table 69. Middle East & Africa Prescription Arthritis Medications Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Prescription Arthritis Medications Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Prescription Arthritis Medications Revenue Market Share by Countries (2015-2020)
Table 72. Global Prescription Arthritis Medications Sales by Type (2015-2020) (K Units)
Table 73. Global Prescription Arthritis Medications Sales Share by Type (2015-2020)
Table 74. Global Prescription Arthritis Medications Revenue by Type (2015-2020) (USD Million)
Table 75. Global Prescription Arthritis Medications Revenue Share by Type (2015-2020)
Table 76. Global Prescription Arthritis Medications Sales by Application (2015-2020) (K Units)
Table 77. Global Prescription Arthritis Medications Sales Share by Application (2015-2020)
Table 78. Global Prescription Arthritis Medications Sales Forecast by Regions (2021-2025) (K Units)
Table 79. Global Prescription Arthritis Medications Market Share Forecast by Regions (2021-2025)
Table 80. Global Prescription Arthritis Medications Sales Forecast by Type (2021-2025) (K Units)
Table 81. Global Prescription Arthritis Medications Market Share Forecast by Type (2021-2025)
Table 82. Global Prescription Arthritis Medications Sales Forecast by Application (2021-2025)
Table 83. Global Prescription Arthritis Medications Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Prescription Arthritis Medications Picture
Figure 2. Global Sales Market Share of Prescription Arthritis Medications by Type in 2019
Figure 3. Oral Picture
Figure 4. Topical Picture
Figure 5. Prescription Arthritis Medications Sales Market Share by Application in 2018
Figure 6. Hospital Pharmacies Picture
Figure 7. Online Pharmacies Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Global Prescription Arthritis Medications Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Prescription Arthritis Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Prescription Arthritis Medications Sales Market Share by Manufacturer in 2019
Figure 30. Global Prescription Arthritis Medications Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Prescription Arthritis Medications Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Prescription Arthritis Medications Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Prescription Arthritis Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Prescription Arthritis Medications Revenue Market Share by Regions (2015-2020)
Figure 37. Global Prescription Arthritis Medications Revenue Market Share by Regions in 2018
Figure 38. North America Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
Figure 39. Europe Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
Figure 41. South America Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Prescription Arthritis Medications Sales and Growth Rate (2015-2020)
Figure 43. North America Prescription Arthritis Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Prescription Arthritis Medications Sales Market Share by Countries (2015-2020)
Figure 45. North America Prescription Arthritis Medications Sales Market Share by Countries in 2018
Figure 46. North America Prescription Arthritis Medications Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Prescription Arthritis Medications Revenue Market Share by Countries in 2018
Figure 48. United States Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Prescription Arthritis Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Prescription Arthritis Medications Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Prescription Arthritis Medications Revenue Market Share by Countries in 2019
Figure 54. Germany Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Prescription Arthritis Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Prescription Arthritis Medications Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Prescription Arthritis Medications Revenue Market Share by Regions 2019
Figure 62. China Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Prescription Arthritis Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Prescription Arthritis Medications Sales Market Share by Countries in 2019
Figure 69. South America Prescription Arthritis Medications Revenue Market Share by Countries in 2019
Figure 70. Brazil Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Prescription Arthritis Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Prescription Arthritis Medications Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Prescription Arthritis Medications Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Prescription Arthritis Medications Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Prescription Arthritis Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Prescription Arthritis Medications Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Prescription Arthritis Medications Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Prescription Arthritis Medications Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Prescription Arthritis Medications Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Prescription Arthritis Medications Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Prescription Arthritis Medications Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Prescription Arthritis Medications Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
処方用皮膚科薬品の世界市場 2020年 Market Overview The global Prescription Dermatological Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Presc…- 処方用整形外科薬品の世界市場 2020年 Market Overview The global Prescription Orthopedic Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prescription Or…
- 処方用胃腸薬の世界市場 2020年 Market Overview The global Prescription Gastrointestinal Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prescript…
- 皮膚疾患治療薬の世界市場 2020年 Market Overview The global Dermatological Disorders Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dermatol…
- 処方用呼吸器治療薬の世界市場 2020年 Market Overview The global Prescription Respiratory Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prescription R…